Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP837039.RAkvCfIEpVDDWCaFdhWrKGj5X_AxN2cRo--_hawM6fWtw130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP837039.RAkvCfIEpVDDWCaFdhWrKGj5X_AxN2cRo--_hawM6fWtw130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP837039.RAkvCfIEpVDDWCaFdhWrKGj5X_AxN2cRo--_hawM6fWtw130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP837039.RAkvCfIEpVDDWCaFdhWrKGj5X_AxN2cRo--_hawM6fWtw130_provenance.
- NP837039.RAkvCfIEpVDDWCaFdhWrKGj5X_AxN2cRo--_hawM6fWtw130_assertion description "[By contrast, the galectin-2-encoding gene LGALS2 3279TT homozygote variant has been demonstrated to exert protection against myocardial infarction by reducing the transcriptional level of galectin-2, thereby leading to a reduced extracellular secretion of LTA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP837039.RAkvCfIEpVDDWCaFdhWrKGj5X_AxN2cRo--_hawM6fWtw130_provenance.
- NP837039.RAkvCfIEpVDDWCaFdhWrKGj5X_AxN2cRo--_hawM6fWtw130_assertion evidence source_evidence_literature NP837039.RAkvCfIEpVDDWCaFdhWrKGj5X_AxN2cRo--_hawM6fWtw130_provenance.
- NP837039.RAkvCfIEpVDDWCaFdhWrKGj5X_AxN2cRo--_hawM6fWtw130_assertion SIO_000772 19013708 NP837039.RAkvCfIEpVDDWCaFdhWrKGj5X_AxN2cRo--_hawM6fWtw130_provenance.
- NP837039.RAkvCfIEpVDDWCaFdhWrKGj5X_AxN2cRo--_hawM6fWtw130_assertion wasDerivedFrom befree-20140225 NP837039.RAkvCfIEpVDDWCaFdhWrKGj5X_AxN2cRo--_hawM6fWtw130_provenance.
- NP837039.RAkvCfIEpVDDWCaFdhWrKGj5X_AxN2cRo--_hawM6fWtw130_assertion wasGeneratedBy ECO_0000203 NP837039.RAkvCfIEpVDDWCaFdhWrKGj5X_AxN2cRo--_hawM6fWtw130_provenance.
- befree-20140225 importedOn "2014-02-25" NP837039.RAkvCfIEpVDDWCaFdhWrKGj5X_AxN2cRo--_hawM6fWtw130_provenance.